The history of understanding the role of growth factors in wound healing

Wounds

Volumn 8, Issue 3, 1996, Pages 78-90

  Brantigan, Charles O ^a,b  

^a PRESBYTERIAN ST LUKE S MEDICAL CENTER   (United States)

^b Historic Gebhard Mansion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030541765     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (103)

1. Point of View, Inc. Market research report 1996.
2. Standard & Poors. Stock Guide and Standard & Poors Industry Report.
3. Pare A. The first discourse wherein wounds made by gunshot are freed from being burnt or cauterized according to Vigoes methode. In: Keynes G (ed). The Apologie and Treatise of Ambrose Pare. London, England, Falcon Educational Books, 1951, p 137.
4. Semelweis IF. The etiology, the concept and the prophylaxis of childbed fever. Classics of Surgery Library. New York, NY, Gryphon Editions, 1994 (translated by FP Murphy).
5. von Eiselsberg A. Ten commandments for the military surgeon. Surg Gynecol Obstet 1915;20:717-718.
6. Wiesner J. Elementarstruktur. Wien, 1892 in Sandblom, 1949.
7. Carrel A. Rejuvenation of cultures of tissues. JAMA 1911;57:1611.
8. Najafi H. Dr. Alexis Carrel and tissue culture. JAMA 1983;250:1086-1089.
9. Carrel A. The treatment of wounds: a first article. JAMA 1910;55:2148-2150.
10. DeNouy P. Cicatrization of wounds. III. The relation between the age of the patient, the area of the wound, and the index of cicatrization. J Exp Med 1919;24:461-70.
11. Carrel A. Artificial activation of the growth in vitro of connective tissue. J Exp Med 1913;17:14-19.
12. Rutherford RB, Ross R. Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol 1976;69:196-203.
13. Edwards WS, Edwards PD. Alexis Carrel: Visionary Surgeon. Springfield, IL, CC Thomas, 1974.
14. Carrel A, Dehelly G. The Treatment of Infected Wounds. New York, NY, Paul B. Hoeber, 1917.
15. Heggars JP, Sazy JA, Stenberg BD, et al. Bactericidal and wound-healing properties of sodium hypochlorite solutions: The 1991 Lindberg award. J Burn Care Rehab 1991;12:420-424.
16. Hepburn HH. Delayed primary suture of wounds. Brit Med J 1919;1:181-183.
17. Churchill ED. The surgical management of the wounded in the Mediterranean theater at the time of the fall of Rome. Ann Surgery 1944;120:268-283.
18. Haberlant G, Sitzungsber d Preuss. Akad d Wissenschaft 1921;124:221 (quoted by Sandblom, 1949).
19. Baker LE, Carrel A. Action on fibroblasts of the protein fraction of embryonic tissue extract. J Exp Med 1926;44:387-395.
20. Fischer A. The nature of the growth-promoting substances in the embryonic tissue juice. Acta Physiol Scandinav 1941;3:54-70.
21. Nielsen E. Ugeskr Laeg 1936:225-46. In: Waugh WG. Experiments in the acceleration of wound healing. Brit Med J 1940;1:249-252.
22. Nielsen E. Ugeskr Laeg 1936:225-46. In: Waugh WG. Experiments in the acceleration of wound healing. Brit Med J 1940;1:249-252.
23. Waugh WG. Experiments in the acceleration of wound healing. Brit Med J 1940;1:249-252.
24. Young JS, Fisher JA, Young M. Some observation on the healing of experimental wounds in the skin of the rabbit. J Path Bact 1941;52:225-46.
25. Sandblom P. Effect of injury on wound healing. Ann Surgery 1949;129:305-314.
26. Savlov ED, Dunphy JE. The healing of the disrupted and resutured wound. Surgery 1936;36:362-370.
27. Old L. Tumor necrosis factor. Scientific American 1988;258:50-75.
28. Carswell EA, Old L, Kassel RL, et al. An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666.
29. Old L. Tumor necrosis factor (TNF). Science 1985;230:630-33.
30. Haranaka K, Satomi N, Sakurai A, Nariuchi H. Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int J Cancer 1985;36:395-400.
31. Rouzer CA, Cerami A. Hypertriglyceridemia associated with trypanosoma brucei brucei infection in rabbits: role of defective triglyceride removal. Mol Biochem Parasitol 1980;2:31-38.
32. Beutler B, Mahoney N, LeTrang P, et al. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985;161:984-995.
33. Herndon DN, Hayward PG, Rutan RL, et al. Growth hormones and factors in surgical patients. Adv Surgery 1992;25:65-97.
34. Cerami A, Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunology Today 1988;9:28-31.
35. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974;71:1207-1210.
36. Kohler N, Lipton A. Platelets as a source of fibroblast growth-promoting activity. Exp Cell Res 1974;87:297-301.
37. Liebovich SJ, Ross R. A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Path 1976;84:501-513.
38. Sandweiss DJ, Saltzstein HC, Farbman A. The prevention or healing of experimental peptic ulcer in Mann-Williamson dogs with anterior pituitary-like hormone (antuitrin-S), a preliminary report. Am J Digest Dis 1938;5:24-30.
39. Sandweiss DJ. The immunizing effect of the anti-ulcer factor in normal human urine (anthelone) against the experimental gastrojejunal (peptic) ulcer in dogs. Gastroenterology 1943;1:965-69.
40. Cohen S. Isolation of a mouse submaxillary grand protein accelerating in cisor eruption and eyelid opening in the newborn animal. J Biol Chem 1962;237:1555-1562.
41. Hollenberg MD, Cuatrecasas P. Insulin and epidermal growth factor. Human fibroblast receptors related to deoxyribonucleic acid synthesis and amino acid uptake. J Biol Chem 1975;250:3845-3853.
42. Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975;257:325-327.
43. Radford HM, Avenell JA, Panaretto BA. Some effects of epidermal growth factor on reproductive function in Merino Sheep. J Reprod Fert 1987;80:113-8.
44. De Larco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 1978;75:4001-5.
45. Roberts A, Anzano MA, Lamb LC, et al. New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 1981;78:5339-5343.
46. Sporn MB, Roberts AB. A major advance in the use of growth factors to enhance wound healing. J Clin Invest 1993;92:1565-66.
47. Baird A, Wallace PA. Fibroblast growth factors. Brit Med Bulletin 1989;45:438-52.
48. Source: Curative Health Services 1996.
49. Salmon WD, Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 1957;49:825-836.
50. Steenfos HH. Growth factors and wound healing. Scand J Plast Reconstr Hand Surgery 1994;28:95-105.
51. Knighton DR, Fiegel VD, Austin LL, et al. Classification and treatment of chronic nonhealing wounds; successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986;204:322-330.
52. Knighton DR, Ciresi KF, Fiegel VD, et al. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990;170:56-60.
53. Atri SC, Miser J, Bisht D. Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. Surgery 1990;108:508-512.
54. Holloway GA, Steed DL, DeMarco MJ, et al. A randomized, controlled, multicenter, dose response trial of activated platelet supernatant, topical CT-102 in chronic nonhealing diabetic wounds. WOUNDS 1993;5:198-206.
55. Krupski WC, Reilly LM, Percez S, et al. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg 1991;14:526-532.
56. Curative Health Systems, 1996, written communication.
57. Lynch SE, Colvin RB. Antoniades HN. Growth factors in wound healing. J Clin Invest 1989;84:640-646.
58. Knighton DR, Phillips GD, Fiegel VD. Wound healing angiogenesis: Indirect stimulation by basic fibroblast growth factor. J Trauma 1990;30:5134-144.
59. Falanga V. Growth factors in wound healing. Dermatol Clinics 1992;11:667-675.
60. Mooney DP, O'Reilly, Gamelli RL. Tumor necrosis factor and wound healing. Ann Surg 1990;211:124-129.
61. Dvonch VM, Murphey RJ, Matsuoka J, Grotendorst GR. Changes in growth factor levels in human wound fluid. Surgery 1991;112:18-23.
62. Matsuoka J, Grotendorst GR. Two peptides related to platelet-derived growth factor are present in human wound fluid. Proc Natl Acad Sci USA 1898;86:4416-4420.
63. Sprugel K, McPherson JM, Clowes AW, Ross R. Effects of growth factors in vivo I cell ingrowth into porous subcutaneous chambers. Am J Path 1987;129:601-613.
64. Chleboun JO, Martins R, Rao S. Laser Doppler velocimetry and platelet-derived growth factor as prognostic indicators for the healing of ulcers and ischemic lesions of the lower limb. Cardiovasc Surgery 1995;3:285-290.
65. Pierce GF, Tarpley JE, Yangihara D, et al. Platelet-derived growth factor (BB homodimer), transforming growth factor-ß1, and basic fibroblast growth factor in dermal wound healing. Am J Pathol 1992;140:1375-88.
66. Robson MC, Phillips LG, Thomason A, et al. Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surgery 1992;29:193-201.
67. Mustoe TA, Cutler NR, Allman RM, et al. A phase II study to evaluate recombinant platelet-derived growth factor BB in the treatment of stage 3 and 4 pressure ulcers. Arch Surg 1994;129:213.
68. Steed DL. The diabetic ulcer study group, clinical evaluation of recombinant human platelet derived growth factor (rhPDGF-BB) for the treatment of lower extremity diabetic ulcers. J Vasc Surgery 1995;21:71-81.
69. Oka Y, Orth D. Human plasma epidermal growth factor/ß-urogastrone is associated with blood platelets. J Clin Invest 1983;72:249-59.
70. Grotendorst GR, Soma Y, Takehara K, Charette M. EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J Cell Physiol 1989;139:617-623.
71. Hirata Y, Moore GW, Bertagna C, Orth DN. Plasma concentration of immunoreactive human epidermal growth factor (urogastrone) in man. J Clin Endocrinol Metab 1980;50:4404.
72. Franklin JD, Lynch JB. Effects of topical applications of epidermal growth factor on wound healing. Plast Reconstr Surg 1979;64:766-770.
73. Greaves MW. Lack of effect of topically applied epidermal growth factor (EGF) on epidermal growth in man in vivo. Clin Exper Dermal 1980;5:101-103.
74. Brown GL, Nanney LB, Griffin J, Cramer AB, et al. Enhancement of wound healing by topical treatment with epidermal growth factor. New Engl J Med 1989;321:76-79.
75. Brown GL, Curtsinger L, Jurkiewicz MJ, et al. Stimulation of healing of chronic wounds by epidermal growth factor. Plast Reconstr Surg 1991;88:189-196.
76. Falanga V, Eaglstein WH, Bucalo B, et al. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol 1992;18:604-606.
77. Cohen IK, Crossland MC, Garrett A, Diegelmann RF. Topical application of epidermal growth factor onto partial thickness wounds in human volunteers does not enhance reepithelialization. Plast Reconstr Surg 1995;96:251.
78. Girdler NM, McGurk M, Aqual S, Prince M. The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration. Am J Clin Oncol 1995;18:403-406.
79. Falanga V. Growth factors and chronic wounds: The need to understand the microenvironment. J Dermatol 1992;19:667-672.
80. Schultz GS, White M, Mitchell R, et al. Epithelial wound healing enhanced by transforming growth factor-α and vaccinia growth factor. Science 1987;235:350-351.
81. Mustoe TA, Pierce GF, Thomason A, et al. Accelerated healing of indsional wounds in rats included by transforming growth factor-ß. Science 1987;237:1333-1336.
82. Beck LS, DeGuzman L, Lee WP, et al. One systemic administration of transforming growth factor-ß1 reverses age- or glucocorticoid-impaired wound healing. J Clin Invest 1993;92:2841-2849.
83. McGee GS, Davidson JM, Buckley A, et al. Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 1988;45:145-53.
84. Hayward P, Hokanson J, Heggars, et al. Fibroblast growth factor reverses the bacterial retardation of wound contraction. Amer J Surgery 1992;163:288-293.
85. Phillips LG, Abdulla KM, Geldner PD, et al. Application of basic fibroblast growth factor may reverse diabetic wound healing impairment. Ann Plast Surgery 1993;31:331-334.
86. King L, Norris D, Carter M, et al. Basic fibroblast growth factor (BFGF) in treatment of leg ulcers secondary to venous stasis and diabetes mellitus (abstract). WOUNDS 1993;5:45.
87. Richard JL, Parker-Richard C, Daures JP, et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. Diabetes Care 1995;18:64-69.
88. Hunt TK, Knighton DR, Thakral KK, et al. Studies on inflammation and wound healing. Angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages. Surgery 1984;96:48-54.
89. Greenburg GH, Hunt TK. The proliferative response in vitro of vascular endothelial and smooth muscle cells exposed to wound fluids and macrophages. J Cell Physiol 1978;97:353-360.
90. Banda MJ, Knighton DR, Hunt TK, Werb Z. Isolation of a nonmitogenic angiogenesis factor from wound fluid. Proc Natl Acad Sci USA 1982;70:7773-7777.
91. Katz MH, Alvarez AF, Kirsner RS, Eaglstein WH, Falanga V. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Amer Acad Dermatol 1991;25:1054-58.
92. Grayson LS, Hansbrough JF, Zapata-Sirvent RL, et al. Quantitation of cytokine levels in skin graft donor site wound fluid. Burns 1993;19:401-5.
93. Rotatori DS, Caffee HH, Copeland EM, et al. Growth factors are present in human wound fluid. Surg Forum 1990;41:627-30.
94. Bennett NT, Schultz GS. Growth factors and wound healing, parts I and II. Am J Surg 1993;165(6):728-737 and 166(1):74-81.
95. Bennett NT, Schultz GS. Growth factors and wound healing, parts I and II. Am J Surg 1993;165(6):728-737 and 166(1):74-81.
96. Grinnell F, Ho CH, Wysocki A. Degradation of fibronectin and vitronectin in chronic wound fluid: Analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Derm 1992;98:410-416.
97. Wysocki AB, Grinnell F. Fibronectin profiles in normal and chronic wound fluid. Lab Invest 1990;63:825-31.
98. Grinnell F, Zhu M. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J Invest Derm 1994;103:155-161.
99. Herndon DN, Nguyen TT, Gilpin DA. Growth factors: local and systemic. Arch Surgery 1993;128:1227-1233.
100. Sporn MB, Roberts AB. Peptide growth factors are multifunctional. Nature 1988;332:217-219.
101. Parker RC. Physiologische eigenschaften mesenchymaler zellen in vitro. Arch Exp Zellforsch 1929;8:340-58 (quoted in Fischer, 1941).
102. Bernstein EF, Harisiadis L, Salomen G. Transforming growth factor-ß improves healing of radiation impaired wounds. J Invest Dermatol 1991;97:430-434.
103. Home E. Practical Observations on the Treatment of Ulcers on the Legs: Considered as a Brandi of Military Surgery. London, England, W Bulmer and Co, 1801.